FDA vaccines chief who ran afoul of pharma to depart
Vinay Prasad’s exit — his second from the agency under Commissioner Marty Makary’s leadership — comes as he’s drawn sharp criticism in recent weeks about his handling of rare disease therapy candidates before the agency.
